New price cuts on innovator drugs in Spain could have domino effect across Europe
This article was originally published in Scrip
The pharmaceutical industry in Spain has condemned new price cuts on patented medicines announced yesterday by president, José Luis Rodríguez Zapatero. Industry has warned that the reductions could have a knock-on effect on prices elsewhere in Europe thanks to reference pricing.
You may also be interested in...
Insurers argue that better use of real world data and multiple pricing assessments could help lower drug prices in Germany.
To keep investors happy, companies will have to start showing that their high-priced advanced therapies offset costs elsewhere in the health care system.
To maintain high prices and avoid access restrictions, companies marketing advanced therapies will have to show payers that their products save money elsewhere in the healthcare system.